Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma

被引：1
|
作者：
Fukumoto, Takeshi [1 ]
Horita, Nobuyuki [2 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 147卷
关键词：
STAGE IV MELANOMA; DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB; PLACEBO;
D O I：
10.1016/j.ejca.2021.01.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitor for a Pediatric Melanoma Patient
    Itakura, Yosuke
    Uchimura, Shinsuke
    Kawakami, Ryota
    Shimizu, Daisuke
    Kageyama, Reiko
    Senoo, Ayumu
    Matsushita, Yuki
    Sakaguchi, Kimiyoshi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S119 - S119
  • [42] Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor
    Abdel-Wahab, Noha
    Kus, Teresa
    Bentebibel, Salah-Eddine
    McQuade, Jennifer Leigh
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Wong, Michael K. K.
    Tawbi, Hussein A.
    Davies, Michael A.
    Peterson, Susan K.
    Shete, Sanjay
    Yee, Cassian
    Kavelaars, Annemieke
    Suarez-Almazor, Maria E.
    Diab, Adi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
    Patterson, Andrew
    Auslander, Noam
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [44] Thrombotic thrombocytopenic purpura associated to dual checkpoint inhibitor therapy for metastatic melanoma
    Lafranchi, Anne
    Springe, Dirk
    Rupp, Adrienne
    Ebnother, Lukas
    Zschiedrich, Stefan
    CEN CASE REPORTS, 2020, 9 (03) : 289 - 290
  • [45] Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma Natural Progression and Management
    Huffman, Brandon M.
    Kottschade, Lisa A.
    Kamath, Patrick S.
    Markovic, Svetomir N.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 760 - 765
  • [46] Thrombotic thrombocytopenic purpura associated to dual checkpoint inhibitor therapy for metastatic melanoma
    Anne Lafranchi
    Dirk Springe
    Adrienne Rupp
    Lukas Ebnöther
    Stefan Zschiedrich
    CEN Case Reports, 2020, 9 : 289 - 290
  • [47] Transcriptome-based Biomarker for guidance of Immune Checkpoint Inhibitor Therapy in Melanoma
    Rotter, B.
    Hirsch, B.
    Feist, L.
    Al-Boutros, T.
    Hummel, M.
    Assaf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 123 - 123
  • [48] Immune checkpoint blockades therapy of melanoma
    Liu, Hong
    Ou, Jiarui
    Hung, Mien-Chie
    Chen, Xiang
    SCIENCE BULLETIN, 2023, 68 (04) : 356 - 358
  • [49] Immune sensitization of melanoma to checkpoint inhibitor therapy using acoustically active nanoparticles
    Henderson, Michael Ian
    Xiang, Li
    Drennan, Samuel
    Yi, Xin
    Fischer, Jared
    Yildirim, Adem
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
    Andrew Patterson
    Noam Auslander
    Nature Communications, 13
12345